T1	Pharmacological_substance 20 28	coumarin
N1000 	Reference T1 MeSH:C030123	coumarin
T2	Pharmacological_substance 121 129	Coumarin
N1001 	Reference T2 MeSH:C030123	Coumarin
T3	Pharmacological_substance 267 275	coumarin
N1002 	Reference T3 MeSH:C030123	coumarin
T4	Disorder 351 371	venous insufficiency
N1 	Reference T4 UMLS:C0042485	venous insufficiency
T5	Pharmacological_substance 411 419	coumarin
N1003 	Reference T5 MeSH:C030123	coumarin
T8	Pharmacological_substance 505 513	coumarin
N1004 	Reference T8 MeSH:C030123	coumarin
T10	Disorder 698 720	Adverse drug reactions
N2 	Reference T10 UMLS:C0041755	Adverse drug reactions
T11	Disorder 821 839	allergic reactions
N3 	Reference T11 UMLS:C1527304	allergic reactions
N4 	Reference T11 UMLS:C0020517	allergic reactions
T12	Disorder 930 952	adverse drug reactions
N5 	Reference T12 UMLS:C0041755	adverse drug reactions
T13	Disorder 1058 1066	jaundice
N6 	Reference T13 UMLS:C0022346	jaundice
T14	Disorder 1106 1113	fatigue
N7 	Reference T14 UMLS:C0015672	fatigue
T18	Disorder 1239 1248	Hepatitis
N8 	Reference T18 UMLS:C0019158	Hepatitis
T28	Pharmacological_substance 29 39	troxerutin
N1005 	Reference T28 MeSH:C005865	troxerutin
T29	Pharmacological_substance 525 535	troxerutin
N1006 	Reference T29 MeSH:C005865	troxerutin
T30	Pharmacological_substance 95 102	placebo
N1007 	Reference T30 MeSH:D010919	placebo
T9	Pharmacological_substance 206 213	placebo
N1008 	Reference T9 MeSH:D010919	placebo
T7	Pharmacological_substance 557 564	placebo
N1009 	Reference T7 MeSH:D010919	placebo
T23	Combination 40 51	combination
T32	Speculation_cue 313 322	evaluated
T34	Subject 460 472	114 patients
T36	Subject 548 551	117
T41	Disorder 1023 1049	Specific clinical symptoms
N9 	Reference T41 UMLS:C1457887	Specific clinical symptoms
T44	Disorder 1118 1128	exhaustion
N10 	Reference T44 UMLS:C0392674	exhaustion
T45	Subject 1087 1096	1 patient
T47	Pharmacological_substance 1230 1237	placebo
N1010 	Reference T47 MeSH:D010919	placebo
T48	Disorder 1268 1289	diseases of the liver
N11 	Reference T48 UMLS:C0023895	diseases of the liver
T49	Subject 1379 1382	man
T58	Speculation_cue 1168 1172	risk
T59	Disorder 1177 1193	elevation of LFT
N12 	Reference T59 UMLS:C0496870	elevation of LFT
T60	Disorder 1384 1397	LFT elevation
N13 	Reference T60 UMLS:C0496870	LFT elevation
T63	Disorder 145 186	elevate liver function tests (LFT) values
T51	Pharmacological_substance 300 306	SB-LOT
T25	Pharmacological_substance 491 497	SB-LOT
T16	Pharmacological_substance 1208 1214	SB-LOT
T19	Pharmacological_substance 1369 1375	SB-LOT
T35	Pharmacological_substance 1435 1441	SB-LOT
T50	Speculation_cue 1423 1427	risk
T65	Manner_cue 1419 1422	low
T39	Speculation_cue 0 14	Safety aspects
T40	Speculation_cue 382 388	report
